98 related articles for article (PubMed ID: 8887306)
1. Altered growth hormone (GH) secretion in women gaining weight during hormone replacement therapy (HRT).
Hartmann BW; Kirchengast S; Albrecht AE; Söregi G; Huber JC
Maturitas; 1996 Aug; 25(1):29-34. PubMed ID: 8887306
[TBL] [Abstract][Full Text] [Related]
2. Effects of estradiol valerate on growth hormone and prolactin response to growth hormone-releasing hormone stimulation in pre- and postmenopausal women.
Hartmann BW; Kirchengast S; Albrecht AE; Laml T; Huber JC; Söregi G
Gynecol Endocrinol; 1997 Feb; 11(1):43-50. PubMed ID: 9086339
[TBL] [Abstract][Full Text] [Related]
3. Effect of hormone replacement therapy on growth hormone stimulation in women with premature ovarian failure.
Hartmann BW; Kirchengast S; Albrecht A; Huber JC; Söregi G
Fertil Steril; 1997 Jul; 68(1):103-7. PubMed ID: 9207592
[TBL] [Abstract][Full Text] [Related]
4. Body composition modulates the effects of hormone replacement therapy on growth hormone and insulin-like growth factor-I levels in postmenopausal women.
Figueroa A; Going SB; Milliken LA; Blew R; Sharp S; Lohman TG
Gynecol Obstet Invest; 2002; 54(4):201-6. PubMed ID: 12592062
[TBL] [Abstract][Full Text] [Related]
5. Oral dehydroepiandrosterone supplementation modulates spontaneous and growth hormone-releasing hormone-induced growth hormone and insulin-like growth factor-1 secretion in early and late postmenopausal women.
Genazzani AD; Stomati M; Strucchi C; Puccetti S; Luisi S; Genazzani AR
Fertil Steril; 2001 Aug; 76(2):241-8. PubMed ID: 11476767
[TBL] [Abstract][Full Text] [Related]
6. Effects of hormone replacement therapy on growth hormone secretion patterns in correlation to somatometric parameters in healthy postmenopausal women.
Hartmann B; Kirchengast S; Albrecht A; Laml T; Bikas D; Huber J
Maturitas; 1995 Nov; 22(3):239-46. PubMed ID: 8746882
[TBL] [Abstract][Full Text] [Related]
7. Modulatory effects of a synthetic steroid (tibolone) and estradiol on spontaneous and GH-RH-induced GH secretion in postmenopausal women.
Genazzani AD; Gamba O; Nappi L; Volpe A; Petraglia F
Maturitas; 1997 Sep; 28(1):27-33. PubMed ID: 9391992
[TBL] [Abstract][Full Text] [Related]
8. Effects of recombinant human insulin-like growth factor I administration on spontaneous and growth hormone (GH)-releasing hormone-stimulated GH secretion in anorexia nervosa.
Gianotti L; Pincelli AI; Scacchi M; Rolla M; Bellitti D; Arvat E; Lanfranco F; Torsello A; Ghigo E; Cavagnini F; Müller EE
J Clin Endocrinol Metab; 2000 Aug; 85(8):2805-9. PubMed ID: 10946886
[TBL] [Abstract][Full Text] [Related]
9. Increased serum levels of growth hormone and insulin-like growth factor-I associated with simultaneous decrease of circulating insulin in postmenopausal women receiving hormone replacement therapy.
Fonseca E; Ochoa R; Galván R; Hernández M; Mercado M; Zárate A
Menopause; 1999; 6(1):56-60. PubMed ID: 10100181
[TBL] [Abstract][Full Text] [Related]
10. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
Khorram O; Laughlin GA; Yen SS
J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536
[TBL] [Abstract][Full Text] [Related]
11. Somatotropic axis and body weight in pre-menopausal and post-menopausal women: evidence for a neuroendocrine derangement, in absence of changes of insulin-like growth factor binding protein concentrations.
Bernardi F; Petraglia F; Seppala M; Spinetti A; Bertolini S; Ferdeghini M; Genazzani AR
Hum Reprod; 1998 Feb; 13(2):279-84. PubMed ID: 9557822
[TBL] [Abstract][Full Text] [Related]
12. Oral estradiol administration modulates continuous intravenous growth hormone (GH)-releasing peptide-2-driven GH secretion in postmenopausal women.
Shah N; Evans WS; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 2000 Aug; 85(8):2649-59. PubMed ID: 10946861
[TBL] [Abstract][Full Text] [Related]
13. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
14. GH release after GHRH plus arginine administration in obese and overweight women with polycystic ovary syndrome.
Orio F; Palomba S; Colao A; Russo T; Dentico C; Tauchmanovà L; Savastano S; Nappi C; Sultan C; Zullo F; Lombardi G
J Endocrinol Invest; 2003 Feb; 26(2):117-22. PubMed ID: 12739737
[TBL] [Abstract][Full Text] [Related]
15. Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study.
Bellantoni MF; Vittone J; Campfield AT; Bass KM; Harman SM; Blackman MR
J Clin Endocrinol Metab; 1996 Aug; 81(8):2848-53. PubMed ID: 8768841
[TBL] [Abstract][Full Text] [Related]
16. Effect of menopause and different combined estradiol-progestin regimens on basal and growth hormone-releasing hormone-stimulated serum growth hormone, insulin-like growth factor-1, insulin-like growth factor binding protein (IGFBP)-1, and IGFBP-3 levels.
Cano A; Castelo-Branco C; Tarín JJ
Fertil Steril; 1999 Feb; 71(2):261-7. PubMed ID: 9988395
[TBL] [Abstract][Full Text] [Related]
17. Impact of estradiol supplementation on dual peptidyl drive of GH secretion in postmenopausal women.
Veldhuis JD; Evans WS; Bowers CY
J Clin Endocrinol Metab; 2002 Feb; 87(2):859-66. PubMed ID: 11836333
[TBL] [Abstract][Full Text] [Related]
18. Effects of aging and estradiol supplementation on GH axis dynamics in women.
Lieman HJ; Adel TE; Forst C; von Hagen S; Santoro N
J Clin Endocrinol Metab; 2001 Aug; 86(8):3918-23. PubMed ID: 11502833
[TBL] [Abstract][Full Text] [Related]
19. Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: role of sex hormone replacement.
Span JP; Pieters GF; Sweep CG; Hermus AR; Smals AG
J Clin Endocrinol Metab; 2000 Mar; 85(3):1121-5. PubMed ID: 10720049
[TBL] [Abstract][Full Text] [Related]
20. Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotrophic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth hormone-releasing hormone pulsatile infusion in men.
Iranmanesh A; South S; Liem AY; Clemmons D; Thorner MO; Weltman A; Veldhuis JD
Eur J Endocrinol; 1998 Jul; 139(1):59-71. PubMed ID: 9703380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
